At Kimialys, we provide vaccine developers and manufacturers with reliable and precise biomolecule characterization data and concentration measurements. Our proprietary and patented chemical treatment, applied to chips and nanoparticles, allows for unprecedented Surface Plasmon Resonance analysis (affinity, avidity), as well as sensitive detection assays such as rapid tests and immuno-PCR. Our technology and expertise support the development of antibody, peptide, or oligonucleotide-based vaccines, accelerating and optimizing the pre-clinical phase for pharmaceutical companies.
We are an ISO 9001 certified company based in France, working with laboratories across Europe, North America, and Asia.